2-[7-Chloro-5-(2-chlorophenyl)-1-(2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 2-[7-Chloro-5-(2-chlorophenyl)-1-(2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetic acid
• 英文别名: 2-[7-chloro-5-(2-chlorophenyl)-1-(2,2-dimethylpropyl)-2-oxo-5H-4,1-benzoxazepin-3-yl]acetic acid
• 化学式: C₂₂H₂₃Cl₂NO₄
• 分子量: 436.3
• InChiKey: BHDQOMHFEOHAQK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• 4,1-Benzoxazepin derivatives as squalene synthase inhibitors and their use in the treatment of hypercholesteremia and as fungicides
  申请人：TAKEDA CHEMICAL INDUSTRIES, LTD.

  公开号：EP0567026A1

  公开（公告）日：1993-10-27

  4,1-Benzoxazepin-2-one derivatives represented by the formula (I) : , wherein R1 stands for hydrogen atom or an optionally substituted hydrocarbon group; R2 and R3 independently stand for hydrogen atom, an optionally substituted lower alkyl group, an optionally substituted phenyl group or an optionally substituted aromatic heterocyclic group ; X stands for a bond or a spacer having the chain length of 1 to 7 atoms ; Y stands for an optionally esterified or thioesterified carboxyl group, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted phenyl group, an optionally substituted carbamoyl group or a N-containing heterocyclic residue having hydrogen atom capable of being deprotonated ; provided that, when X is methylene and R1 is not an alkyl group having carbon atoms of more than 4, Y is neither carboxyl group nor alkoxycarbonyl group ; and the ring A may optionally be substituted, or salts thereof, which are useful for inhibiting squalene synthetase and fungal growth.

  4,1-苯并氧氮杂卓-2-酮衍生物，由式(I)代表： 其中 R1 代表氢原子或任选取代的烃基；R2 和 R3 分别代表氢原子、任选取代的低级烷基、任选取代的苯基或任选取代的芳香杂环基；X 代表键或链长为 1 至 7 个原子的间隔物；Y 代表任选酯化或硫酯化的羧基、任选取代的羟基、任选取代的氨基、任选取代的苯基、任选取代的氨基甲酰基或含有能被去质子化的氢原子的含 N 杂环残基；条件是，当 X 为亚甲基且 R1 不是碳原子数超过 4 的烷基时，Y 既不是羧基也不是烷氧羰基；并且环 A 可以任选被取代，或其盐类可用于抑制角鲨烯合成酶和真菌生长。
• Production of optically active compounds
  申请人：TAKEDA CHEMICAL INDUSTRIES, LTD.

  公开号：EP0710725A1

  公开（公告）日：1996-05-08

  A process for producing an optically active form of a compound of formula (I) wherein R₁ represents hydrogen or a hydrocarbon group that may be substituted; R₂ and R₃ independently represent hydrogen, a hydrocarbon group that may be substituted, or a heteroaromatic group that may be substituted; X' represents a substituent comprising an esterified carboxyl group or an acylated hydroxyl group; ring A represents a benzene ring that may be substituted or a heteroaromatic ring that may be substituted; ring J' represents a 7- or 8-membered heterocyclic ring containing at most 3 hetero-atoms as ring-constituent members, which may have a further substituent or substituents in addition to R₁, R₂, R₃ and X', and C* denotes a chiral carbon atom or a salt thereof, which comprises subjecting the racemic compound of the formula (I) or a salt thereof, or alternatively a racemic starting compound for synthesizing the compound of the formula (I) to enzymatically enantioselective hydrolysis to provide an optically active form thereof.

  一种生产式(I)化合物光学活性形式的工艺 其中 R₁ 代表氢或可被取代的烃基；R₂ 和 R₃ 独立地代表氢、可被取代的烃基或可被取代的杂芳基；X'代表由酯化羧基或酰化羟基组成的取代基；环 A 代表可被取代的苯环或可被取代的杂芳环；环 J'代表最多含有 3 个杂原子作为环取代基的 7 元或 8 元杂环，除了 R₁、 R₂、R₃ 和 X'之外，还可以有一个或多个取代基，C* 表示手性碳原子或其盐、其中包括将式（I）的外消旋化合物或其盐，或合成式（I）化合物的外消旋起始化合物进行酶法对映选择性水解，以提供其光学活性形式。
• Condensed seven- or eight-membered heterocyclic compounds useful as squalene synthetase inhibitors
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0645378B1

  公开（公告）日：2000-08-23
• US5698691A
  申请人：——

  公开号：US5698691A

  公开（公告）日：1997-12-16
• US5726306A
  申请人：——

  公开号：US5726306A

  公开（公告）日：1998-03-10